The microtome market size in 2021 stood at US$ 141.21million and is foreseen to reach US$ 254.29million by 2031. The market is expected to register a CAGR of 6.6% in 2023–2031. Technological advancements in disease diagnosis are likely to remain key microtome market trends.
The increasing number of chronic diseases among people, growing R&D spending by pharmaceutical giants, and increased investment in R&D activities are prime contributing factors for an extraordinary growth rate of the market. In addition, the developing healthcare infrastructure through international collaboration and joint ventures with market leaders for drug discovery, development and commercialization also propels the market growth. These all factors are anticipated to benefit the microtome market during the forecast period.
Microtome is a device used for sample preparation in laboratories. Microtomes prepare slices of biological specimens into evenly thin sections for a detailed microscopic examination. Present microtomes have three basic components: body, knife & knife attachment, and material- or tissue-holder. The increasing cases of chronic diseases such as cancer are fueling the growth of the market as microtomes are essential for biopsy. According to the GLOBOCAN Report 2020, ~19.29 million new cancer cases have been reported globally, along with 9.95 million reported deaths caused by the disease. According to the WHO, Japan reported 1.02 million new cancer cases in 2020. Cancer is one of the top causes of death worldwide, and its prevalence is increasing the number of histopathology tests. A tissue pathology examination is required to determine a malignant tumor to predict the outcome of cancer.
Digital diagnosis has become a crucial aspect of surgical pathology in the lab. Nowadays, formalin-fixed paraffin-embedded slides are digitally scanned into high-resolution digital images. These are then examined, analyzed, and shared with other pathologists for better diagnostic results. With the total number of new cancer cases expected to rise globally, pathology laboratories are seeking ways to meet increased service demand. This has led to the increasing adoption of digital pathology, allowing laboratories to work more efficiently. Clinical laboratories have been widely using microtomes for diagnosis purposes. For instance, the Tissue-Tek Auto Section automated microtome from Sakura Finetek offers the benefit of automation over manual microtomes. Moreover, the increasing volume of routine tissue examinations also increases the demand for automated microtomes. To handle such a large sample size, automated microtomes provide numerous benefits to pathologies, such as high speed, improved efficiency, and reduced strain. Digital penetrations in hospitals and diagnostic laboratories are helping to improve diagnostic capabilities, thereby driving market growth.
Personalized medicine is becoming the trademark of cancer treatment; it is a constantly emerging approach based on customized treatments per the individual genetic structure. The rising adoption of personalized medicine has led to an increase in demand for the use of human tissue as the field requires human tissue to develop innovative tests. Microtomes are widely used to prepare formalin-fixed paraffin-embedded tissue samples and to design high-quality biological materials for biobanks, which are used for various research applications. Moreover, microtomes are also used to prepare tissue microarrays composed of small tissue 0.6 mm in diameter embedded in paraffin blocks. Precision medicine is being considered as one of the most promising approaches to tackle diseases such as cancer, neurodegenerative diseases, and rare genetic conditions. Precision medicine utilizes an individual's genomic information to offer targeted treatment for a particular indication. The increasing prevalence of a number of chronic diseases has increased the demand for biologics, drugs for orphan diseases, and personalized medicines.
Key segments that contributed to the derivation of the microtome market analysis are product, technology, and end user.
The geographic scope of the microtome market report is mainly divided into five regions: North America, Asia Pacific, Europe, Middle East & Africa, and South & Central America.
North America has dominated the microtome market. North America market is expanding due to several factors, including the rising development in the field of biotechnology and pharmaceutical sectors, enhanced clinical and diagnostics research, and growing government support of research. In addition, growing research in the healthcare sectors and increasing innovations for various therapeutic areas are leading to market growth in the region. Similarly, the presence of various international and domestic players that are continuously involved in the development of various laboratory instruments required in clinical and diagnostic research labs also augments the growth of the market in the region. Asia Pacific is anticipated to grow with the highest CAGR in the coming years.
The regional trends and factors influencing the Microtome Market throughout the forecast period have been thoroughly explained by the analysts at Insight Partners. This section also discusses Microtome Market segments and geography across North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America.
| Report Attribute | Details |
|---|---|
| Market size in 2021 | US$ 141.21 Million |
| Market Size by 2031 | US$ 254.29 Million |
| Global CAGR (2023 - 2031) | 6.6% |
| Historical Data | 2021-2022 |
| Forecast period | 2024-2031 |
| Segments Covered |
By Product
|
| Regions and Countries Covered | North America
|
| Market leaders and key company profiles |
The Microtome Market market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.
Market players density refers to the distribution of firms or companies operating within a particular market or industry. It indicates how many competitors (market players) are present in a given market space relative to its size or total market value.
Major Companies operating in the Microtome Market are:
Disclaimer: The companies listed above are not ranked in any particular order.
The microtome market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. The following is a list of developments in the market for microtome and strategies:
The “Microtome Market Size and Forecast (2021–2031)” report provides a detailed analysis of the market covering below areas: